ArticleBiomedicines2021

Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells.

Masanobu Tsubaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.